251 related articles for article (PubMed ID: 22265694)
1. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
[TBL] [Abstract][Full Text] [Related]
2. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
Donnelly RF; Garland MJ; Alkilani AZ
Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
[TBL] [Abstract][Full Text] [Related]
3. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution.
Donnelly RF; Garland MJ; Morrow DI; Migalska K; Singh TR; Majithiya R; Woolfson AD
J Control Release; 2010 Nov; 147(3):333-41. PubMed ID: 20727929
[TBL] [Abstract][Full Text] [Related]
5. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
[TBL] [Abstract][Full Text] [Related]
6. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.
Pawar KR; Smith F; Kolli CS; Babu RJ
J Pharm Sci; 2013 Oct; 102(10):3784-91. PubMed ID: 23955316
[TBL] [Abstract][Full Text] [Related]
7. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.
Pawar K; Kolli CS; Rangari VK; Babu RJ
J Pharm Sci; 2017 Jul; 106(7):1814-1820. PubMed ID: 28343991
[TBL] [Abstract][Full Text] [Related]
8. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery.
Pamornpathomkul B; Ngawhirunpat T; Tekko IA; Vora L; McCarthy HO; Donnelly RF
Eur J Pharm Sci; 2018 Aug; 121():200-209. PubMed ID: 29777854
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of proteins using a combination of iontophoresis and microporation.
Bai Y; Sachdeva V; Kim H; Friden PM; Banga AK
Ther Deliv; 2014 May; 5(5):525-36. PubMed ID: 24998272
[TBL] [Abstract][Full Text] [Related]
10. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
[TBL] [Abstract][Full Text] [Related]
11. Transdermal Delivery of Sumatriptan Succinate Using Iontophoresis and Dissolving Microneedles.
Ronnander JP; Simon L; Koch A
J Pharm Sci; 2019 Nov; 108(11):3649-3656. PubMed ID: 31374318
[TBL] [Abstract][Full Text] [Related]
12. Transdermal on-demand drug delivery based on an iontophoretic hollow microneedle array system.
Detamornrat U; Parrilla M; Domínguez-Robles J; Anjani QK; Larrañeta E; De Wael K; Donnelly RF
Lab Chip; 2023 May; 23(9):2304-2315. PubMed ID: 37073607
[TBL] [Abstract][Full Text] [Related]
13. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
14. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
16. Influence of molecular weight on transdermal delivery of model macromolecules using hydrogel-forming microneedles: potential to enhance the administration of novel low molecular weight biotherapeutics.
Hutton ARJ; McCrudden MTC; Larrañeta E; Donnelly RF
J Mater Chem B; 2020 May; 8(19):4202-4209. PubMed ID: 32292995
[TBL] [Abstract][Full Text] [Related]
17. Increased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO prevention.
Xiao S; Yan Y; Zhao J; Zhang Y; Feng N
Int J Pharm; 2020 Feb; 575():118962. PubMed ID: 31857187
[TBL] [Abstract][Full Text] [Related]
18. Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs.
Quinn HL; Bonham L; Hughes CM; Donnelly RF
J Pharm Sci; 2015 Oct; 104(10):3490-500. PubMed ID: 26149914
[TBL] [Abstract][Full Text] [Related]
19. Processing difficulties and instability of carbohydrate microneedle arrays.
Donnelly RF; Morrow DI; Singh TR; Migalska K; McCarron PA; O'Mahony C; Woolfson AD
Drug Dev Ind Pharm; 2009 Oct; 35(10):1242-54. PubMed ID: 19555249
[TBL] [Abstract][Full Text] [Related]
20. Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin.
Demir YK; Akan Z; Kerimoglu O
PLoS One; 2013; 8(5):e63819. PubMed ID: 23675508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
